A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer. - Wikidata - awgldk - TriplyDB

A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.

A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.

http://www.wikidata.org/entity/Q35407573

about

Identification of Peptides Derived from the C-terminal Domain of Fibulin-7 Active for Endothelial Cell Adhesion and Tube Formation Disruption.Effects of endothelial cell proliferation and migration rates in a computational model of sprouting angiogenesis.Novel insight into triple-negative breast cancers, the emerging role of angiogenesis, and antiangiogenic therapy.Gene delivery nanoparticles to modulate angiogenesis.Tyrosine kinase blocking collagen IV-derived peptide suppresses ocular neovascularization and vascular leakage.Biomimetic peptide display from a polymeric nanoparticle surface for targeting and antitumor activity to human triple-negative breast cancer cells.Computational modeling of synergistic interaction between αVβ3 integrin and VEGFR2 in endothelial cells: Implications for the mechanism of action of angiogenesis-modulating integrin-binding peptides

P2860

Q36827495-1AE66058-7D0F-4427-A51E-BEC61C461636 Q37411899-1E7D9DF5-8892-4B50-8406-6E25961C9217 Q39000232-17533F37-0DD5-4880-B2EC-AE7018F98CAC Q39027588-D9DCEF71-6BA8-40FB-9D3D-83404D0253E2 Q49334226-3F94D9FB-F367-46A5-87C5-1D3FC20D9BB6 Q50102174-76BEFDA1-4DC2-4AC1-B87C-AFBA6657652F Q57467572-03990212-8B96-4B8A-91AF-4056C868328F

P2860

A biomimetic collagen derived peptide exhibits anti-angiogenic activity in triple negative breast cancer.

http://www.wikidata.org/entity/Q35407573

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

A biomimetic collagen derived ...... triple negative breast cancer.

@ast

A biomimetic collagen derived ...... triple negative breast cancer.

@en

type

label

A biomimetic collagen derived ...... triple negative breast cancer.

@ast

A biomimetic collagen derived ...... triple negative breast cancer.

@en

prefLabel

A biomimetic collagen derived ...... triple negative breast cancer.

@ast

A biomimetic collagen derived ...... triple negative breast cancer.

@en

P1433

Q35407573-8DDFE63D-2868-44DD-910D-339D7688F76F

P1476

Q35407573-5B93A95D-80E0-4756-B0CA-3456AB6E67F4

P2093

Q35407573-03D5766D-2FD7-4F8E-A50A-1FE3848CC030

Q35407573-81E85640-8AF2-496D-B145-8CAB2A15BABC

Q35407573-C1A503C4-591D-4F3E-A19B-DD3271A53D0F

Q35407573-CE4B8D49-75C6-4FE4-B7AE-0ED21F269F4E

Q35407573-D76DF683-1625-42EA-B428-E5D8CBBEAFD1

Q35407573-E2EB90BE-990C-442B-A2E0-3CCB5561E529

P2860

Q35407573-0B5EF810-CB10-4EB1-B260-64AD2D8DDF86

Q35407573-12EBAD64-468C-4D68-8734-08934E24E797

Q35407573-176866AB-9D4F-4B3D-9E8C-E9604CBD4207

Q35407573-263A348F-B8A5-4E01-9AD8-9D1482A50E59

Q35407573-30196C2C-D597-4568-A5FD-C2274D0124DF

Q35407573-36A58956-21FB-4B0D-A51E-71573F2657F4

Q35407573-3DB5A98C-04EF-4F55-B3E1-C478F0B807A5

Q35407573-40C7F671-EDD8-43A7-BE9C-0959017E6095

Q35407573-46CA6709-A700-46A2-B581-18F08CA8AFBD

Q35407573-479A41CA-DC41-4CC7-B94B-87FA5B751D3A

P304

Q35407573-6D0EFE1C-4A48-46DD-96A1-31451F4A6614

P31

Q35407573-BF723533-A6EE-4964-966B-DB3077D2B2DC

P356

Q35407573-5516628D-9791-4D8A-A4CC-1E2CE6BCDDBB

P407

Q35407573-64CD0A55-65C1-4C8F-B3C3-269AB81E6B9C

P433

Q35407573-CA4DEE6A-E980-4062-8444-90B3CD5FB090

P478

Q35407573-0DE18B53-B1E4-4EC9-9939-79316BA05C46

P50

Q35407573-05B8830F-D234-4F0B-8916-5811036DF42C

Q35407573-5CDE360C-F800-4CB9-9BDA-D8C3727509BE

P577

Q35407573-62653B87-116A-49CE-95F7-84BC264770CD

P5875

Q35407573-19AC1B17-2EE9-43C8-8F9C-64E15CA15A01

P698

Q35407573-40446978-D7A2-4B3F-B9D1-195FD63FEC7D

P921

Q35407573-9416BEB1-34EE-41AA-A7D7-62D9904F0ADA

P932

Q35407573-98028619-C144-4CE3-952F-B6B2FE096422

P356

JOURNAL.PONE.0111901

P1433

P1476

A biomimetic collagen derived ...... triple negative breast cancer.

@en

P2093

Elena V Rosca

http://www.w3.org/2001/XMLSchema#string

Jacob E Koskimaki

http://www.w3.org/2001/XMLSchema#string

Marie-France Penet

http://www.w3.org/2001/XMLSchema#string

Niranjan B Pandey

http://www.w3.org/2001/XMLSchema#string

Noriko Mori

http://www.w3.org/2001/XMLSchema#string

Zaver M Bhujwalla

http://www.w3.org/2001/XMLSchema#string

P2860

LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan

Cooperation between integrin alphavbeta3 and VEGFR2 in angiogenesis

Tumor angiogenesis: therapeutic implications

Integrin β3 crosstalk with VEGFR accommodating tyrosine phosphorylation as a regulatory switch

Role of angiogenesis in tumor growth and metastasis

Integrins in cancer: biological implications and therapeutic opportunities

Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model.

Anti-angiogenic peptides for cancer therapeutics

Rap1 promotes VEGFR2 activation and angiogenesis by a mechanism involving integrin αvβ₃.

Vascular permeability during antiangiogenesis treatment: MR imaging assay results as biomarker for subsequent tumor growth in rats.

P304

e111901

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0111901

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Aleksander S. Popel

P577

2014-11-10T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

268228387

http://www.w3.org/2001/XMLSchema#string

P698

25384034

http://www.w3.org/2001/XMLSchema#string

P921

P932

4226498

http://www.w3.org/2001/XMLSchema#string